Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 88 entries
Sorted by: Best Match Show Resources per page
History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.

Journal of clinical medicine

Andrès E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Séverac F, Tebacher M, Gottenberg JE, Weber JC, Kaltenbach G, Goichot B, Sibilia J, Korganow AS, Herbrecht R.
PMID: 28954408
J Clin Med. 2017 Sep 26;6(10). doi: 10.3390/jcm6100092.

BACKGROUND: Despite major advances in its prevention and treatment, febrile neutropenia remains a most concerning complication of cancer chemotherapy. Outside the oncology setting, however, only few data are currently available on febrile neutropenia related to non-chemotherapy drugs. We report...

Cite
Andrès E, Mourot-Cottet R, Maloisel F, et al. History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs. J Clin Med. 2017;6(10)doi: 10.3390/jcm6100092.
Andrès, E., Mourot-Cottet, R., Maloisel, F., Keller, O., Vogel, T., Séverac, F., Tebacher, M., Gottenberg, J. E., Weber, J. C., Kaltenbach, G., Goichot, B., Sibilia, J., Korganow, A. S., & Herbrecht, R. (2017). History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs. Journal of clinical medicine, 6(10), . https://doi.org/10.3390/jcm6100092
Andrès, Emmanuel, et al. "History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs." Journal of clinical medicine vol. 6,10 (2017). doi: https://doi.org/10.3390/jcm6100092
Andrès E, Mourot-Cottet R, Maloisel F, Keller O, Vogel T, Séverac F, Tebacher M, Gottenberg JE, Weber JC, Kaltenbach G, Goichot B, Sibilia J, Korganow AS, Herbrecht R. History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs. J Clin Med. 2017 Sep 26;6(10). doi: 10.3390/jcm6100092. PMID: 28954408; PMCID: PMC5664007.
Copy Download .nbib Format: NLM
Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.

Infectious diseases and therapy

Gangneux JP, El Cheikh J, Herbrecht R, Yakoub-Agha I, Quiniou JB, Caillot D, Michallet M.
PMID: 29948621
Infect Dis Ther. 2018 Sep;7(3):309-325. doi: 10.1007/s40121-018-0203-4. Epub 2018 Jun 09.

INTRODUCTION: The frequency of invasive fungal diseases (IFDs) has increased in recent years. Within a context where both treatments and guidelines are fast evolving, we aim to shed new light on IFD management in hematologic departments in France.METHODS: A...

Cite
Gangneux JP, El Cheikh J, Herbrecht R, et al. Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study. Infect Dis Ther. 2018;7(3):309-325doi: 10.1007/s40121-018-0203-4.
Gangneux, J. P., El Cheikh, J., Herbrecht, R., Yakoub-Agha, I., Quiniou, J. B., Caillot, D., & Michallet, M. (2018). Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study. Infectious diseases and therapy, 7(3), 309-325. https://doi.org/10.1007/s40121-018-0203-4
Gangneux, Jean-Pierre, et al. "Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study." Infectious diseases and therapy vol. 7,3 (2018): 309-325. doi: https://doi.org/10.1007/s40121-018-0203-4
Gangneux JP, El Cheikh J, Herbrecht R, Yakoub-Agha I, Quiniou JB, Caillot D, Michallet M. Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study. Infect Dis Ther. 2018 Sep;7(3):309-325. doi: 10.1007/s40121-018-0203-4. Epub 2018 Jun 09. PMID: 29948621; PMCID: PMC6098753.
Copy Download .nbib Format: NLM
Self-organization of multifunctional surfaces--the fingerprints of light on a complex system.

Advanced materials (Deerfield Beach, Fla.)

Reinhardt H, Kim HC, Pietzonka C, Kruempelmann J, Harbrecht B, Roling B, Hampp N.
PMID: 23529920
Adv Mater. 2013 Jun 25;25(24):3313-8. doi: 10.1002/adma.201205031. Epub 2013 Mar 26.

Nanocomposite patterns and nanotemplates are generated by a single-step bottom-up concept that introduces laser-induced periodic surface structures (LIPSS) as a tool for site-specific reaction control in multicomponent systems. Periodic intensity fluctuations of this photothermal stimulus inflict spatial-selective reorganizations, dewetting...

Cite
Reinhardt H, Kim HC, Pietzonka C, et al. Self-organization of multifunctional surfaces--the fingerprints of light on a complex system. Adv Mater. 2013;25(24):3313-8doi: 10.1002/adma.201205031.
Reinhardt, H., Kim, H. C., Pietzonka, C., Kruempelmann, J., Harbrecht, B., Roling, B., & Hampp, N. (2013). Self-organization of multifunctional surfaces--the fingerprints of light on a complex system. Advanced materials (Deerfield Beach, Fla.), 25(24), 3313-8. https://doi.org/10.1002/adma.201205031
Reinhardt, Hendrik, et al. "Self-organization of multifunctional surfaces--the fingerprints of light on a complex system." Advanced materials (Deerfield Beach, Fla.) vol. 25,24 (2013): 3313-8. doi: https://doi.org/10.1002/adma.201205031
Reinhardt H, Kim HC, Pietzonka C, Kruempelmann J, Harbrecht B, Roling B, Hampp N. Self-organization of multifunctional surfaces--the fingerprints of light on a complex system. Adv Mater. 2013 Jun 25;25(24):3313-8. doi: 10.1002/adma.201205031. Epub 2013 Mar 26. PMID: 23529920.
Copy Download .nbib Format: NLM
Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury.

Annals of intensive care

Ehrmann S, Helms J, Joret A, Martin-Lefevre L, Quenot JP, Herbrecht JE, Benzekri-Lefevre D, Robert R, Desachy A, Bellec F, Plantefeve G, Bretagnol A, Dargent A, Lacherade JC, Meziani F, Giraudeau B, Tavernier E, Dequin PF.
PMID: 31549274
Ann Intensive Care. 2019 Sep 23;9(1):106. doi: 10.1186/s13613-019-0580-1.

BACKGROUND: Nephrotoxic drug prescription may contribute to acute kidney injury (AKI) occurrence and worsening among critically ill patients and thus to associated morbidity and mortality. The objectives of this study were to describe nephrotoxic drug prescription in a large...

Cite
Ehrmann S, Helms J, Joret A, et al. Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury. Ann Intensive Care. 2019;9(1):106doi: 10.1186/s13613-019-0580-1.
Ehrmann, S., Helms, J., Joret, A., Martin-Lefevre, L., Quenot, J. P., Herbrecht, J. E., Benzekri-Lefevre, D., Robert, R., Desachy, A., Bellec, F., Plantefeve, G., Bretagnol, A., Dargent, A., Lacherade, J. C., Meziani, F., Giraudeau, B., Tavernier, E., Dequin, P. F. (2019). Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury. Annals of intensive care, 9(1), 106. https://doi.org/10.1186/s13613-019-0580-1
Ehrmann, Stephan, et al. "Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury." Annals of intensive care vol. 9,1 (2019): 106. doi: https://doi.org/10.1186/s13613-019-0580-1
Ehrmann S, Helms J, Joret A, Martin-Lefevre L, Quenot JP, Herbrecht JE, Benzekri-Lefevre D, Robert R, Desachy A, Bellec F, Plantefeve G, Bretagnol A, Dargent A, Lacherade JC, Meziani F, Giraudeau B, Tavernier E, Dequin PF. Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury. Ann Intensive Care. 2019 Sep 23;9(1):106. doi: 10.1186/s13613-019-0580-1. PMID: 31549274; PMCID: PMC6757082.
Copy Download .nbib Format: NLM
A Dodecagonal Quasicrystalline Chalcogenide.

Angewandte Chemie (International ed. in English)

Conrad M, Krumeich F, Harbrecht B.
PMID: 29710900
Angew Chem Int Ed Engl. 1998 Jun 05;37(10):1383-1386. doi: 10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R.

Diffractograms with twelvefold rotational symmetry (depicted on the right) were obtained from the first quasicrystalline chalcogenide Ta

Cite
Conrad M, Krumeich F, Harbrecht B. A Dodecagonal Quasicrystalline Chalcogenide. Angew Chem Int Ed Engl. 1998;37(10):1383-1386doi: 10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R.
Conrad, M., Krumeich, F., & Harbrecht, B. (1998). A Dodecagonal Quasicrystalline Chalcogenide. Angewandte Chemie (International ed. in English), 37(10), 1383-1386. https://doi.org/10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R
Conrad, Matthias, et al. "A Dodecagonal Quasicrystalline Chalcogenide." Angewandte Chemie (International ed. in English) vol. 37,10 (1998): 1383-1386. doi: https://doi.org/10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R
Conrad M, Krumeich F, Harbrecht B. A Dodecagonal Quasicrystalline Chalcogenide. Angew Chem Int Ed Engl. 1998 Jun 05;37(10):1383-1386. doi: 10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R. PMID: 29710900.
Copy Download .nbib Format: NLM
Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement.

Medical mycology

Nivoix Y, Fohrer C, Fornecker L, Herbrecht R.
PMID: 30408917
Med Mycol. 2006 Sep 01;44:S289-S294. doi: 10.1080/13693780600931986.

Despite recent improvements in outcome of invasive aspergillosis there are still high failure and fatality rates. The trial comparing voriconazole to amphotericin B deoxycholate has become a reference for clinical trials in invasive aspergillosis due to the large number...

Cite
Nivoix Y, Fohrer C, Fornecker L, et al. Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement. Med Mycol. 2006;44:S289-S294doi: 10.1080/13693780600931986.
Nivoix, Y., Fohrer, C., Fornecker, L., & Herbrecht, R. (2006). Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement. Medical mycology, 44S289-S294. https://doi.org/10.1080/13693780600931986
Nivoix, Y, et al. "Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement." Medical mycology vol. 44 (2006): S289-S294. doi: https://doi.org/10.1080/13693780600931986
Nivoix Y, Fohrer C, Fornecker L, Herbrecht R. Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement. Med Mycol. 2006 Sep 01;44:S289-S294. doi: 10.1080/13693780600931986. PMID: 30408917.
Copy Download .nbib Format: NLM
Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.

Circulation

Thiele H, Zeymer U, Thelemann N, Neumann FJ, Hausleiter J, Abdel-Wahab M, Meyer-Saraei R, Fuernau G, Eitel I, Hambrecht R, Böhm M, Werdan K, Felix SB, Hennersdorf M, Schneider S, Ouarrak T, Desch S, de Waha-Thiele S.
PMID: 30586721
Circulation. 2018 Nov 11; doi: 10.1161/CIRCULATIONAHA.118.038201. Epub 2018 Nov 11.

BACKGROUND: The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial (Intraaortic Balloon Pump in Cardiogenic Shock II) with subsequent downgrading in international...

Cite
Thiele H, Zeymer U, Thelemann N, et al. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. Circulation. 2018;doi: 10.1161/CIRCULATIONAHA.118.038201.
Thiele, H., Zeymer, U., Thelemann, N., Neumann, F. J., Hausleiter, J., Abdel-Wahab, M., Meyer-Saraei, R., Fuernau, G., Eitel, I., Hambrecht, R., Böhm, M., Werdan, K., Felix, S. B., Hennersdorf, M., Schneider, S., Ouarrak, T., Desch, S., de Waha-Thiele, S. (2018). Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. Circulation, . https://doi.org/10.1161/CIRCULATIONAHA.118.038201
Thiele, Holger, et al. "Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial." Circulation vol. (2018). doi: https://doi.org/10.1161/CIRCULATIONAHA.118.038201
Thiele H, Zeymer U, Thelemann N, Neumann FJ, Hausleiter J, Abdel-Wahab M, Meyer-Saraei R, Fuernau G, Eitel I, Hambrecht R, Böhm M, Werdan K, Felix SB, Hennersdorf M, Schneider S, Ouarrak T, Desch S, de Waha-Thiele S. Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial. Circulation. 2018 Nov 11; doi: 10.1161/CIRCULATIONAHA.118.038201. Epub 2018 Nov 11. PMID: 30586721.
Copy Download .nbib Format: NLM
Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center.

Medicines (Basel, Switzerland)

Andrès E, Lorenzo Villalba N, Mourot-Cottet R, Maloisel F, Tebacher M, Gottenberg JE, Goichot B, Herbrecht R, Zulfiqar AA.
PMID: 32204561
Medicines (Basel). 2020 Mar 19;7(3). doi: 10.3390/medicines7030015.

BACKGROUND: The most important series devoted to antithyroid drug-induced severe neutropenia and agranulocytosis are Japanese studies, almost specifically in relation to the intake of methimazole. The clinical data of 30 Caucasian patients followed up for antithyroid drug-induced neutropenia at...

Cite
Andrès E, Lorenzo Villalba N, Mourot-Cottet R, et al. Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center. Medicines (Basel). 2020;7(3)doi: 10.3390/medicines7030015.
Andrès, E., Lorenzo Villalba, N., Mourot-Cottet, R., Maloisel, F., Tebacher, M., Gottenberg, J. E., Goichot, B., Herbrecht, R., & Zulfiqar, A. A. (2020). Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center. Medicines (Basel, Switzerland), 7(3), . https://doi.org/10.3390/medicines7030015
Andrès, Emmanuel, et al. "Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center." Medicines (Basel, Switzerland) vol. 7,3 (2020). doi: https://doi.org/10.3390/medicines7030015
Andrès E, Lorenzo Villalba N, Mourot-Cottet R, Maloisel F, Tebacher M, Gottenberg JE, Goichot B, Herbrecht R, Zulfiqar AA. Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center. Medicines (Basel). 2020 Mar 19;7(3). doi: 10.3390/medicines7030015. PMID: 32204561; PMCID: PMC7151575.
Copy Download .nbib Format: NLM
"Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft

Harbrecht A, Endlich F, Hackl M, Seyboth K, Lethaus B, Müller LP, Wegmann K.
PMID: 34863911
Ann Anat. 2021 Dec 02;240:151878. doi: 10.1016/j.aanat.2021.151878. Epub 2021 Dec 02.

The aim of this study was to investigate whether life-like fractures of human cadaveric mandibles with a focus on the condylar process and the intact soft tissue envelope could be simulated. A total of nine fresh-frozen human head specimens...

Cite
Harbrecht A, Endlich F, Hackl M, et al. "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Ann Anat. 2021;240:151878doi: 10.1016/j.aanat.2021.151878.
Harbrecht, A., Endlich, F., Hackl, M., Seyboth, K., Lethaus, B., Müller, L. P., & Wegmann, K. (2021). "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft, 240151878. https://doi.org/10.1016/j.aanat.2021.151878
Harbrecht, Andreas, et al. ""Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery." Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft vol. 240 (2021): 151878. doi: https://doi.org/10.1016/j.aanat.2021.151878
Harbrecht A, Endlich F, Hackl M, Seyboth K, Lethaus B, Müller LP, Wegmann K. "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Ann Anat. 2021 Dec 02;240:151878. doi: 10.1016/j.aanat.2021.151878. Epub 2021 Dec 02. PMID: 34863911.
Copy Download .nbib Format: NLM
Training the next generation of animal scientists for South Africa.

Animal frontiers : the review magazine of animal agriculture

Grobler R, de Witt FH, Cason ED, Einkamerer OB, Josling GC, O'Neill HA, Fair MD, Baloyi JJ, MacNeil MD, Neser FWC.
PMID: 32724714
Anim Front. 2020 Jul 23;10(3):10-17. doi: 10.1093/af/vfaa017. eCollection 2020 Jul.

No abstract available.

Cite
Grobler R, de Witt FH, Cason ED, et al. Training the next generation of animal scientists for South Africa. Anim Front. 2020;10(3):10-17doi: 10.1093/af/vfaa017.
Grobler, R., de Witt, F. H., Cason, E. D., Einkamerer, O. B., Josling, G. C., O'Neill, H. A., Fair, M. D., Baloyi, J. J., MacNeil, M. D., & Neser, F. W. C. (2020). Training the next generation of animal scientists for South Africa. Animal frontiers : the review magazine of animal agriculture, 10(3), 10-17. https://doi.org/10.1093/af/vfaa017
Grobler, Rulien, et al. "Training the next generation of animal scientists for South Africa." Animal frontiers : the review magazine of animal agriculture vol. 10,3 (2020): 10-17. doi: https://doi.org/10.1093/af/vfaa017
Grobler R, de Witt FH, Cason ED, Einkamerer OB, Josling GC, O'Neill HA, Fair MD, Baloyi JJ, MacNeil MD, Neser FWC. Training the next generation of animal scientists for South Africa. Anim Front. 2020 Jul 23;10(3):10-17. doi: 10.1093/af/vfaa017. eCollection 2020 Jul. PMID: 32724714; PMCID: PMC7377514.
Copy Download .nbib Format: NLM
Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation.

Nano research

Liu J, Hebbrecht T, Brans T, Parthoens E, Lippens S, Li C, De Keersmaecker H, De Vos WH, De Smedt SC, Boukherroub R, Gettemans J, Xiong R, Braeckmans K.
PMID: 33154805
Nano Res. 2020 Feb;13(2):485-495. doi: 10.1007/s12274-020-2633-z. Epub 2020 Jan 18.

Fluorescence microscopy is the method of choice for studying intracellular dynamics. However, its success depends on the availability of specific and stable markers. A prominent example of markers that are rapidly gaining interest are nanobodies (Nbs, ~ 15 kDa),...

Cite
Liu J, Hebbrecht T, Brans T, et al. Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation. Nano Res. 2020;13(2):485-495doi: 10.1007/s12274-020-2633-z.
Liu, J., Hebbrecht, T., Brans, T., Parthoens, E., Lippens, S., Li, C., De Keersmaecker, H., De Vos, W. H., De Smedt, S. C., Boukherroub, R., Gettemans, J., Xiong, R., & Braeckmans, K. (2020). Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation. Nano research, 13(2), 485-495. https://doi.org/10.1007/s12274-020-2633-z
Liu, Jing, et al. "Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation." Nano research vol. 13,2 (2020): 485-495. doi: https://doi.org/10.1007/s12274-020-2633-z
Liu J, Hebbrecht T, Brans T, Parthoens E, Lippens S, Li C, De Keersmaecker H, De Vos WH, De Smedt SC, Boukherroub R, Gettemans J, Xiong R, Braeckmans K. Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation. Nano Res. 2020 Feb;13(2):485-495. doi: 10.1007/s12274-020-2633-z. Epub 2020 Jan 18. PMID: 33154805; PMCID: PMC7116313.
Copy Download .nbib Format: NLM
Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention.

Journal of cardiovascular development and disease

Schmucker J, Fach A, Osteresch R, Mata Marin LA, Ruehle S, Retzlaff T, Garstka D, Eitel I, Hambrecht R, Wienbergen H.
PMID: 34436225
J Cardiovasc Dev Dis. 2021 Jul 21;8(8). doi: 10.3390/jcdd8080083.

BACKGROUND: Diabetic patients show higher adverse ischemic event rates and mortality when undergoing percutaneous coronary intervention (PCI) in acute myocardial infarctions. Therefore, diabetic patients might benefit even more from modern-generation drug-eluting stents (DES). The aim of the present study...

Cite
Schmucker J, Fach A, Osteresch R, et al. Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. J Cardiovasc Dev Dis. 2021;8(8)doi: 10.3390/jcdd8080083.
Schmucker, J., Fach, A., Osteresch, R., Mata Marin, L. A., Ruehle, S., Retzlaff, T., Garstka, D., Eitel, I., Hambrecht, R., & Wienbergen, H. (2021). Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. Journal of cardiovascular development and disease, 8(8), . https://doi.org/10.3390/jcdd8080083
Schmucker, Johannes, et al. "Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention." Journal of cardiovascular development and disease vol. 8,8 (2021). doi: https://doi.org/10.3390/jcdd8080083
Schmucker J, Fach A, Osteresch R, Mata Marin LA, Ruehle S, Retzlaff T, Garstka D, Eitel I, Hambrecht R, Wienbergen H. Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention. J Cardiovasc Dev Dis. 2021 Jul 21;8(8). doi: 10.3390/jcdd8080083. PMID: 34436225; PMCID: PMC8397182.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 88 entries